Thai Health-risk Transition: A National Cohort Study
Funder
National Health and Medical Research Council
Funding Amount
$1,231,214.00
Summary
Thailand's disease patterns are changing. Some changes are good but others, like emerging diabetes, heart disease and injuries, are of concern. Development-related 'health transition' can be optimised if there is information on new causes of disease - immediate risk factors, and 'upstream' economic, cultural and environmental influences. The team will study this health-risk transition in the whole Thai population - looking back 50 years, then forwards in 100,000 Sukothai Thammathirat Open Univer ....Thailand's disease patterns are changing. Some changes are good but others, like emerging diabetes, heart disease and injuries, are of concern. Development-related 'health transition' can be optimised if there is information on new causes of disease - immediate risk factors, and 'upstream' economic, cultural and environmental influences. The team will study this health-risk transition in the whole Thai population - looking back 50 years, then forwards in 100,000 Sukothai Thammathirat Open University students living all over Thailand and followed for four years. The team will map changing risks and upstream influences, produce information for Thai preventive programs, boost regional research capacity, create a regional partnership, and support PhD and postdoctoral training.Read moreRead less
I am an epidemiologist using large scale cohort study methods to investigate potentially modifiable factors affecting common conditions, particularly those related to ageing.
The Relationship Between Immune Dysregulation, Infection And Cancer Incidence
Funder
National Health and Medical Research Council
Funding Amount
$380,558.00
Summary
The research aims to better understand the relationship between immune dysfunction, infection and the development of cancer. Established scientific methods will be used to examine the incidence and risk factors for cancer in people with impaired immunity, such as organ transplant recipients, and people with autoimmune disease. This knowledge is important in advancing our understanding of the causes of cancer, and in developing appropriate preventive strategies and health care for these people.
Changing Risks Factors And Cancer Outcomes In A Transitional Thai Prospective Cohort
Funder
National Health and Medical Research Council
Funding Amount
$414,453.00
Summary
This study will examine the health consequences of socioeconomic development in Thailand. Patterns of diseases, including the types and rates of diagnosis of cancer, are changing in Thailand as Western lifestyle habits are adopted. The aim of the research is to investigate risk factors for common cancers at the individual level, and the economic, cultural and environmental level. Understanding these risks and the ways they are changing will assist with future planning for cancer control programs
Using Mathematical Models Of Infection To Inform The Design And Analysis Of Epidemiologic Studies.
Funder
National Health and Medical Research Council
Funding Amount
$387,489.00
Summary
Childhood immunisation has been enormously successful at preventing death and disease. Not all vaccines provide life-long protection, however, and booster doses may be required for older children or even adults. Deciding when and how often doses are required depends on how a particular infection is spread within families and the community both before and after vaccine use. We want to understand more about this process and its implications for the ongoing effectiveness of vaccine programs.
Prognostic Factors Following A First Episode Of Central Nervous System Demyelination Suggestive Of Multiple Sclerosis.
Funder
National Health and Medical Research Council
Funding Amount
$719,475.00
Summary
Multiple sclerosis is the second most common cause of neurological morbidity in young Australians after trauma. Knowing who will progress to develop multiple sclerosis after a first attack and at what rate they will progress is an important question as it will allow us to target treatment to those at greatest risk and modify a person's lifestyle to reduce the risk of developing MS or slow their rate of progression.